Research Overview
Human research on dietary anthocyanins has most extensively examined cognitive and affective outcomes, primarily through randomized controlled trials assessing multiple cognitive domains (e.g., short-term memory, executive function, attention, psychomotor performance, and visual–spatial abilities) and, less frequently, mood-related endpoints. The evidence base summarized in the cited systematic review includes 30 RCTs overall, with 14 trials (n = 733) sufficiently comparable for quantitative meta-analysis, indicating that cognition and mood are the dominant areas of clinical investigation to date.
The strongest support from the broader qualitative synthesis suggests potential improvements across several cognitive domains following anthocyanin intake, and a subset of studies reports mood benefits (e.g., reduced fatigue and lower anxiety/depression scores). However, when restricted to meta-analyzable outcomes, pooled effects were not statistically significant for working memory, verbal learning, and immediate or delayed memory, implying that any true effects may be small, domain-specific, or obscured by between-study heterogeneity. Overall, the current clinical literature is suggestive rather than definitive, with signals of benefit that are not consistently confirmed across standardized pooled analyses.
Key gaps include the need for more harmonized trial designs (standardized cognitive test batteries, consistent mood measures, and comparable intervention durations), better characterization of anthocyanin dose, formulation, and food matrix, and improved reporting to enable robust meta-analysis across endpoints. Additional adequately powered RCTs are needed to clarify which cognitive domains are most responsive, to determine whether effects generalize across populations (e.g., healthy adults vs. those with cognitive complaints), and to establish dose–response relationships and durability of effects. Reducing heterogeneity and increasing methodological consistency will be critical to moving the field from promising signals toward firm causal conclusions.
1. What conditions has Anthocyanins been studied for?
Cognitive function outcomes in adults (as assessed in randomized controlled trials), including multiple cognitive domains such as short-term memory, verbal learning, working memory, executive function, visual-spatial function, psychomotor skills, attention, and semantic memory.
Mood-related outcomes in adults, including fatigue and symptoms measured as anxiety and depression scores.
2. Does it work in treating those conditions? Summarize the evidence.
The evidence from the provided systematic review/meta-analysis suggests possible benefits for some cognitive and mood outcomes, but inconsistent and not clearly confirmed effects for several key memory measures when pooled quantitatively.
-
Cognition (overall): The qualitative synthesis across randomized controlled trials reported improvements in several domains after anthocyanin intake (e.g., executive function, attention, psychomotor skills, visual-spatial function, and some memory-related domains).
-
Memory and learning (meta-analysis results): In the meta-analysis of 14 eligible studies (n = 733), there were no statistically significant pooled effects for:
Working memory: Hedges’s g = -0.183 (95% CI -0.407 to 0.041), P = 0.110
Verbal learning: Hedges’s g = 0.054 (95% CI -0.215 to 0.324), P = 0.69
Immediate memory: Hedges’s g = 0.196 (95% CI -0.242 to 0.633), P = 0.38
Delayed memory: Hedges’s g = -0.188 (95% CI -0.629 to -0.252), P = 0.402 (as reported in the abstract)
-
Mood: Across 15 studies assessing mood, 4 reported significant improvements, including anti-fatigue effects and reductions in anxiety and depression scores. This indicates potential benefit, but the majority did not report significant mood effects.
-
Key limitation noted: The review attributes the lack of significant pooled effects in several outcomes likely to study heterogeneity (differences in study design, populations, interventions, and outcome measures).
3. What health benefits does it have?
Based on the abstract, anthocyanin intake shows potential benefits in the following areas, though not all are consistently supported by pooled meta-analytic findings:
Cognitive performance: Qualitative improvements were reported in executive function, attention, psychomotor skills, visual-spatial function, semantic memory, and some memory-related domains (short-term memory and verbal learning/working memory were mentioned in qualitative synthesis).
Mood and mental well-being: Some trials reported anti-fatigue effects and reduced anxiety and depression scores (4 of 15 mood studies).
Overall, the abstract supports a conclusion of potential cognitive and mood benefits, with stronger uncertainty for specific memory outcomes when data are pooled.
4. Does it have any downsides or side effects?
The provided abstract does not report adverse events, side effects, or safety outcomes. Therefore, no evidence-based conclusions about downsides can be drawn from this source alone.
Evidence limitation: Absence of side-effect reporting in the abstract is not proof of safety; it may reflect that safety was not a focus, not systematically collected, or not summarized in the abstract.
Practical implication: To assess downsides reliably, details from the full text (adverse event tables, withdrawal reasons) and additional safety-focused studies would be needed.
5. Is it beneficial or harmful for any genetic variations (pharmacogenomics)?
The provided abstract does not mention pharmacogenomic analyses or differential effects by genotype. As a result:
No specific genetic variants can be identified from this evidence as predicting benefit or harm from anthocyanins.
Evidence limitation: Many nutrition trials do not stratify outcomes by genotype; any pharmacogenomic conclusions would require studies explicitly designed to test gene–nutrient interactions.
References
-
The Effect of Anthocyanins on Cognition: A Systematic Review and Meta-analysis of Randomized Clinical Trial Studies in Cognitively Impaired and Healthy Adults
Elnaz Lorzadeh, Katrina Weston-Green, Steven Roodenrys, Vinicius do Rosario, Katherine Kent (2025)
Upload Whole Genome Sequencing (WGS) raw DNA data today!
Or upload raw DNA data to get started with your free analysis!